about
Sterol Biosynthesis and Azole Tolerance Is Governed by the Opposing Actions of SrbA and the CCAAT Binding ComplexIn vitro antifungal activities of the new triazole UR-9825 against clinically important filamentous fungiEfficacy of echinocandins against murine infections by Diutina (Candida) rugosa.Pithomyces species (Montagnulaceae) from clinical specimens: identification and antifungal susceptibility profiles.RNAi-Based Functional Genomics Identifies New Virulence Determinants in Mucormycosis.Experimental animal models of coccidioidomycosis.Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.Efficacy of liposomal amphotericin B in treatment of systemic murine fusariosis.Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits.In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization.Voriconazole minimum inhibitory concentrations are predictive of treatment outcome in experimental murine infections by Candida glabrata.Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs.Does a triple combination have better activity than double combinations against multiresistant fungi? Experimental in vitro evaluation.Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic miceFusaric acid contributes to virulence of Fusarium oxysporum on plant and mammalian hosts.Voriconazole MICs are predictive for the outcome of experimental disseminated scedosporiosis.Combined antifungal therapy against systemic murine infections by rare Cryptococcus species.Iron competition in fungus-plant interactions: the battle takes place in the rhizosphere.Antifungal therapies in murine infections by Candida kefyr.In Vitro and In Vivo Efficacy of Amphotericin B Combined with Posaconazole against Experimental Disseminated Sporotrichosis.In Vivo Synergy of Amphotericin B plus Posaconazole in Murine Aspergillosis.Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection.In vitro interactions of approved and novel drugs against Paecilomyces spp.In vitro antifungal susceptibilities of uncommon basidiomycetous yeasts.Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata.In vitro antifungal susceptibility of Candida glabrata to caspofungin and the presence of FKS mutations correlate with treatment response in an immunocompromised murine model of invasive infectionExperimental efficacy of anidulafungin against Aspergillus terreus species complex.Virulence and Experimental Treatment of Trichoderma longibrachiatum, a Fungus Refractory to Treatment.Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits.Efficacy of Amphotericin B at Suboptimal Dose Combined with Voriconazole in a Murine Model of Aspergillus fumigatus Infection with Poor In Vivo Response to the Azole.Experimental therapy with azoles against Candida guilliermondii.In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies.In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.Strongyloides stercolaris infection mimicking a malignant tumour in a non-immunocompromised patient. Diagnosis by bronchoalveolar cytology.[Mixed fungal infection in a diabetic patient].Efficacy of intrathecal liposomal amphotericin B plus oral posaconazole in the treatment of acute meningeal cryptococcosis in a murine model.Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis.Different virulence levels of the species of Sporothrix in a murine model.Histopathology and antifungal treatment of experimental murine chromoblastomycosis caused by Cladophialophora carrionii.
P50
Q27312432-2FCEDD7D-5F57-4522-BF6A-5E334A669E28Q28345970-0E20156C-C1D0-4FAD-89B4-EC4D2CF66A82Q31110549-167EEEC5-565C-4BDE-9149-CA590DC8AE1AQ35226424-8AADA5B2-3A9B-4F55-9169-5E94362A3F9FQ36255871-5BE2B45B-BA5E-4BA7-AA16-6A16CD87F462Q36754015-C9ECE936-B387-4F8A-82B1-2B8D7F2888F9Q39627878-A21FB37E-3F17-4829-AAE4-1D242C836AFEQ39652173-0A359280-6C4E-469C-B368-2F355057A3A7Q39755529-EEAAC6EE-07F6-4E51-879E-44BA23EFDB14Q39913400-D0AA601B-750F-4506-A733-E227B181D142Q39920649-FB6ED894-19FC-421A-ADA2-506D29E17B4FQ40165489-01930B2B-FAD3-4BBA-B62F-0D21E192E166Q40309440-78996726-05D1-42B9-B223-1EEDFFD113A3Q40345252-AB6162AE-2792-457F-8BC0-8CE3F47DDADDQ40369620-8E44F686-0002-467F-A758-9EBF5C9253D4Q40392406-DBC44D74-C4C8-44A9-8D7F-E6F70F71023CQ40518953-C2495175-F850-4291-ACF4-8F34CB056B04Q40797653-B988D7D1-9911-4B88-AE54-F4250FB87196Q40799658-258F0BC5-3F2C-49FE-AE08-A77FF475BC97Q40898822-1E68EC38-6A1F-4641-A410-0D2844D95F14Q40936437-66C942C4-7788-4A8A-A4E0-11FBF28EFF32Q40957704-1BFD44B1-CAC6-41C0-AE3D-4BE90952CEC4Q40967988-C9D1A53F-9F60-441F-B038-96424CE2DBEFQ40968349-3D6D358A-72BE-4C00-B72B-7DAC15AD9A31Q40988680-FA61E77D-3524-4241-84DC-3D45E5852C20Q41079741-6D777CA1-8196-4EA7-B084-4A96E7284C51Q41226559-6CCB9B44-8120-4C05-9BDE-05746A936C8BQ41843810-3C93548E-13FF-4E80-8E59-F3DE945126E5Q42211382-DEA6E6B3-6DFB-4793-9D97-816AF1C75B2FQ42573050-F86DD11B-DB69-48A4-B19F-88CC35ED7FFFQ42657625-710846D5-7A15-4524-85CC-C28985B66FFEQ42689671-82FEF50A-9AE7-4BC5-92EC-C13F9356878BQ42707819-AE2EEF61-5FBF-43F1-9340-DEB87C01083FQ42872151-4010C54D-607A-4EF1-B205-4C2EE219D825Q43010280-ACCDE3D5-1008-40C1-9A7B-CA4E1F4BB606Q43014286-95F4FDBC-D1A7-4876-B8DA-08C3CBBC587BQ43599913-31024B47-A8CC-4F65-9EA5-D5C8C863FB7FQ44111081-A897FBE0-11BC-4337-A75B-5C4BC13DD505Q44607554-684CCFBC-2DBD-4810-9580-CD512E2A054EQ44752247-8B29592D-7307-45CE-83C2-E07F8CF69A41
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Javier Capilla
@ast
Javier Capilla
@en
Javier Capilla
@es
Javier Capilla
@nl
Javier Capilla
@sl
type
label
Javier Capilla
@ast
Javier Capilla
@en
Javier Capilla
@es
Javier Capilla
@nl
Javier Capilla
@sl
prefLabel
Javier Capilla
@ast
Javier Capilla
@en
Javier Capilla
@es
Javier Capilla
@nl
Javier Capilla
@sl
P106
P1153
36783309600
7003550906
P21
P31
P496
0000-0002-0765-6403